Chinese Journal of Cancer Research

The Chinese Journal of Cancer Research publishes clinical and translational cancer research from China and beyond, was founded in 1988 with a 2025 Journal Impact Factor of 6.7《中国癌症研究》（Chinese Journal of Cancer Research）发表来自中国及世界各地的肿瘤临床与转化研究，1988 年创办，2025 年影响因子为 6.7

Scope

• The journal covers clinical oncology and cancer epidemiology in China该刊覆盖中国的肿瘤临床与流行病学研究
• Prevention, screening and early diagnosis are central subjects预防、筛查与早期诊断是核心主题
• Molecular and translational cancer research is covered分子与转化肿瘤研究在其范围
• Radiotherapy, surgery and systemic treatment are within scope放疗、外科与全身治疗同样收录
• Cancer statistics and registry analyses are published肿瘤统计与登记分析均在发表之列
• Reviews of cancer control policy are welcomed肿瘤防控政策的综述受到欢迎

History

• The journal was founded in 1988 as a Chinese outlet for cancer research该刊 1988 年创办，是中国的肿瘤研究学术园地
• It has been indexed in MEDLINE and the Science Citation Index Expanded期刊已被（MEDLINE）与（Science Citation Index Expanded）收录
• Its authorship has widened from domestic groups towards international collaboration作者群体从国内团队扩展到国际合作研究
• The journal is published by Chinese Journal of Cancer Research, under print ISSN 1000-9604, electronic ISSN 1993-0631该刊由（Chinese Journal of Cancer Research）出版，印刷 ISSN 为 1000-9604，电子 ISSN 为 1993-0631。-
• Its Journal Impact Factor was 5.087 in 2021 and reached 6.7 in 2025, with the reported series 6.7, 6.3, 4.026, 5.087其影响因子由 2025 年的 6.7、2024 年的 6.3、2022 年的 4.026、2021 年的 5.087 等年度数据构成，最新为 2025 年的 6.7。

Editors

• An editor-in-chief is supported by associate editors in medical and basic oncology主编由临床肿瘤与基础肿瘤方向的副编辑协助
• The journal publishes original articles, reviews and epidemiological reports期刊发表原创论文、综述与流行病学报告
• It welcomes multicentre studies conducted in China欢迎在中国开展的多中心研究
• It is indexed in the Science Citation Index Expanded, MEDLINE, PubMed and Scopus该刊被（Science Citation Index Expanded）、（MEDLINE）、（PubMed）与（Scopus）收录。